Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) was the target of a large drop in short interest in the month of October. As of October 15th, there was short interest totalling 3,550,000 shares, a drop of 5.1% from the September 30th total of 3,740,000 shares. Based on an average daily trading volume, of 1,270,000 shares, the days-to-cover ratio is presently 2.8 days.
Wall Street Analyst Weigh In
ISRG has been the subject of several research reports. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their target price for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Morgan Stanley lifted their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a report on Monday, July 15th. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.
Read Our Latest Stock Report on Intuitive Surgical
Insider Activity
Hedge Funds Weigh In On Intuitive Surgical
Several hedge funds have recently bought and sold shares of the company. Mirador Capital Partners LP raised its position in Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after acquiring an additional 50 shares during the last quarter. Advisors Asset Management Inc. lifted its position in shares of Intuitive Surgical by 18.1% in the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock valued at $2,945,000 after acquiring an additional 1,129 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its position in Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after purchasing an additional 76,649 shares in the last quarter. Brookstone Capital Management raised its stake in Intuitive Surgical by 22.4% in the 2nd quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock valued at $5,340,000 after purchasing an additional 2,289 shares during the last quarter. Finally, M&G Plc lifted its holdings in Intuitive Surgical by 53.5% in the 2nd quarter. M&G Plc now owns 5,069 shares of the medical equipment provider’s stock valued at $2,256,000 after purchasing an additional 1,766 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Intuitive Surgical Stock Performance
ISRG stock traded down $8.24 during trading on Thursday, reaching $505.53. 504,062 shares of the company were exchanged, compared to its average volume of 1,458,326. The stock’s 50 day moving average price is $489.74 and its 200 day moving average price is $445.30. Intuitive Surgical has a 52-week low of $260.17 and a 52-week high of $523.34. The company has a market cap of $180.06 billion, a P/E ratio of 82.60, a PEG ratio of 5.11 and a beta of 1.39.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Stock Splits, Do They Really Impact Investors?
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- What Makes a Stock a Good Dividend Stock?
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Short Selling: How to Short a Stock
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.